In silico analysis of non-structural protein 12 sequences from SARS-COV-2 found in Manaus, Amazonas, Brazil, reveals mutations linked to higher transmissibility
Authors:
- Fernando B. ZanchiFZFernando B. Zanchi
- Gabriel Eduardo M. FerreiraGFGabriel Eduardo M. Ferreira
- Luis André M. MariúbaLMLuis André M. Mariúba
- Juliane C. GlóriaJGJuliane C. Glória
- Valdinete A. Do NascimentoVNValdinete A. Do Nascimento
- Victor C. DE SouzaVSVictor C. DE Souza
- André DE Lima G. CoradoACAndré DE Lima G. Corado
- Fernanda O. Do NascimentoFNFernanda O. Do Nascimento
- Ágatha Kélly A. DA CostaÁCÁgatha Kélly A. DA Costa
- Débora Camila G. DuarteDDDébora Camila G. Duarte
- George Allan V. DA SilvaGSGeorge Allan V. DA Silva
- Matilde DEL Carmen C. MejíaMMMatilde DEL Carmen C. Mejía
Open Access
- 1 January 2024
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 96 (2) , e20231336
Abstract
The disease coronavirus COVID-19 has been the cause of millions of deaths worldwide. Among the proteins of SARS-CoV-2, non-structural protein 12 (NSP12) plays a key role during COVID infection and is part of the RNA-dependent RNA polymerase complex. The monitoring of NSP12 polymorphisms is extremely important for the design of new antiviral drugs and monitoring of viral evolution. This study analyzed the NSP12 mutations detected in circulating SARS-CoV-2 during the years 2020 to 2022 in the population of the city of Manaus, Amazonas, Brazil. The most frequent mutations found were P323L and G671S. Reports in the literature indicate that these mutations are related to transmissibility efficiency, which may have contributed to the extremely high numbers of cases in this location. In addition, two mutations described here (E796D and R914K) are close and have RMSD that is similar to the mutations M794V and N911K, which have been described in the literature as influential on the performance of the NSP12 enzyme. These data demonstrate the need to monitor the emergence of new mutations in NSP12 in order to better understand their consequences for the treatments currently used and in the design of new drugs.Keywords
This publication has 29 references indexed in Scilit:
- Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitroBiochimie, 2022
- Genomic characterization of SARS‐CoV‐2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteinsJournal of Medical Virology, 2021
- Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutationsInfection, Genetics and Evolution, 2021
- Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNAMolecular Cell, 2020
- Infectivity of SARS-CoV-2: there Is Something More than D614G?Journal of Neuroimmune Pharmacology, 2020
- Favipiravir, an anti-influenza drug against life-threatening RNA virus infectionsPharmacology & Therapeutics, 2020
- T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infectionsAntiviral Research, 2009
- Protein Structure Modeling with MODELLER2008
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004